Peroxisome Proliferator-activated Receptors in Atherosclerosis and Inflammation—An Update

Author： Elangbam Chandikumar S.   Tyler Ronald D.   Lightfoot Ruth M.  

Publisher： Ashgate Publishing Ltd

ISSN： 0192-6233

Source： Toxicologic Pathology, Vol.29, Iss.2, 2001-03, pp. : 224-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Decreased Longevity and Enhancement of Age-Dependent Lesions in Mice Lacking the Nuclear Receptor Peroxisome Proliferator-Activated Receptor  (PPAR)

By Howroyd Paul   Swanson Cyndi   Dunn Corrie   Cattley Russell   Corton J.  

Toxicologic Pathology, Vol. 32, Iss. 5, 2004-01 ,pp. : 591-599

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Inflammation and Cancer

By COUSSENS LISA  

Toxicologic Pathology, Vol. 32, Iss. 6, 2004-11 ,pp. : 732-732

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Role of Thyroid Hormones in Hepatic Effects of Peroxisome Proliferators

By Miller Richard T.   Scappino Lori A.   Long Sarah M.   Corton J. Christopher  

Toxicologic Pathology, Vol. 29, Iss. 1, 2001-01 ,pp. : 149-155

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Stent-assisted angioplasty for intracranial atherosclerosis

By Nakahara Toshinori   Sakamoto Shigeyuki   Hamasaki Osamu   Sakoda Katsuaki  

Neuroradiology, Vol. 44, Iss. 8, 2002-08 ,pp. : 706-710

Springer Publishing Company

Access to resources Recommend Favorite

Regadenoson: A focused update

By Ghimire Gopal  

Journal of Nuclear Cardiology, Vol. 20, Iss. 2, 2013-04 ,pp. : 284-288

Springer Publishing Company

Access to resources Recommend Favorite